Terms: = Leukemia AND CTCF, P49711, 10664, ENSG00000102974
102 results:
1. DARDN: A Deep-Learning Approach for ctcf Binding Sequence Classification and Oncogenic Regulatory Feature Discovery.
Cho HJ; Wang Z; Cong Y; Bekiranov S; Zhang A; Zang C
Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397134
[TBL] [Abstract] [Full Text] [Related]
2. Promoter-centred chromatin interactions associated with EVI1 expression in EVI1+3q- myeloid leukaemia cells.
Ng HL; Robinson ME; May PC; Innes AJ; Hiemeyer C; Feldhahn N
Br J Haematol; 2024 Mar; 204(3):945-958. PubMed ID: 38296260
[TBL] [Abstract] [Full Text] [Related]
3. Enhancer-activated RET confers protection against oxidative stress to KMT2A-rearranged acute myeloid leukemia.
Frett B; Stephens KE; Koss B; Melnyk S; Farrar J; Saha D; Roy Choudhury S
Cancer Sci; 2024 Mar; 115(3):963-973. PubMed ID: 38226414
[TBL] [Abstract] [Full Text] [Related]
4. The PENGUIN approach to reconstruct protein interactions at enhancer-promoter regions and its application to prostate cancer.
Armaos A; Serra F; Núñez-Carpintero I; Seo JH; Baca SC; Gustincich S; Valencia A; Freedman ML; Cirillo D; Giambartolomei C; Tartaglia GG
Nat Commun; 2023 Dec; 14(1):8084. PubMed ID: 38057321
[TBL] [Abstract] [Full Text] [Related]
5. Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors.
Llinàs-Arias P; Ensenyat-Mendez M; Íñiguez-Muñoz S; Orozco JIJ; Valdez B; Salomon MP; Matsuba C; Solivellas-Pieras M; Bedoya-López AF; Sesé B; Mezger A; Ormestad M; Unzueta F; Strand SH; Boiko AD; Hwang ES; Cortés J; DiNome ML; Esteller M; Lupien M; Marzese DM
Mol Cancer; 2023 Nov; 22(1):190. PubMed ID: 38017545
[TBL] [Abstract] [Full Text] [Related]
6. An alternative NURF complex sustains acute myeloid leukemia by regulating the accessibility of insulator regions.
Radzisheuskaya A; Peña-Rømer I; Lorenzini E; Koche R; Zhan Y; Shliaha PV; Cooper AJ; Fan Z; Shlyueva D; Johansen JV; Hendrickson RC; Helin K
EMBO J; 2023 Dec; 42(24):e114221. PubMed ID: 37987160
[TBL] [Abstract] [Full Text] [Related]
7. Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases.
Peroni E; Gottardi M; D'Antona L; Randi ML; Rosato A; Coltro G
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895004
[TBL] [Abstract] [Full Text] [Related]
8. Epigenetic balance ensures mechanistic control of MLL amplification and rearrangement.
Gray ZH; Chakraborty D; Duttweiler RR; Alekbaeva GD; Murphy SE; Chetal K; Ji F; Ferman BI; Honer MA; Wang Z; Myers C; Sun R; Kaniskan HÜ; Toma MM; Bondarenko EA; Santoro JN; Miranda C; Dillingham ME; Tang R; Gozani O; Jin J; Skorski T; Duy C; Lee H; Sadreyev RI; Whetstine JR
Cell; 2023 Oct; 186(21):4528-4545.e18. PubMed ID: 37788669
[TBL] [Abstract] [Full Text] [Related]
9. Nucleosome repositioning in chronic lymphocytic leukemia.
Piroeva KV; McDonald C; Xanthopoulos C; Fox C; Clarkson CT; Mallm JP; Vainshtein Y; Ruje L; Klett LC; Stilgenbauer S; Mertens D; Kostareli E; Rippe K; Teif VB
Genome Res; 2023 Oct; 33(10):1649-1661. PubMed ID: 37699659
[TBL] [Abstract] [Full Text] [Related]
10. DeSUMOylation of chromatin-bound proteins limits the rapid transcriptional reprogramming induced by daunorubicin in acute myeloid leukemias.
Boulanger M; Aqrouq M; Tempé D; Kifagi C; Ristic M; Akl D; Hallal R; Carusi A; Gabellier L; de Toledo M; Sigurdsson JO; Kaoma T; Andrieu-Soler C; Forné T; Soler E; Hicheri Y; Gueret E; Vallar L; Olsen JV; Cartron G; Piechaczyk M; Bossis G
Nucleic Acids Res; 2023 Sep; 51(16):8413-8433. PubMed ID: 37462077
[TBL] [Abstract] [Full Text] [Related]
11. NPM1 mutation reprograms leukemic transcription network via reshaping TAD topology.
Lai Q; Hamamoto K; Luo H; Zaroogian Z; Zhou C; Lesperance J; Zha J; Qiu Y; Guryanova OA; Huang S; Xu B
Leukemia; 2023 Aug; 37(8):1732-1736. PubMed ID: 37365294
[TBL] [Abstract] [Full Text] [Related]
12. Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent ctcf inactivating mutations in acute T cell leukemia.
Smits WK; Vermeulen C; Hagelaar R; Kimura S; Vroegindeweij EM; Buijs-Gladdines JGCAM; van de Geer E; Verstegen MJAM; Splinter E; van Reijmersdal SV; Buijs A; Galjart N; van Eyndhoven W; van Min M; Kuiper R; Kemmeren P; Mullighan CG; de Laat W; Meijerink JPP
Cell Rep; 2023 Apr; 42(4):112373. PubMed ID: 37060567
[TBL] [Abstract] [Full Text] [Related]
13. Validation of the new EPIC DNA methylation microarray (900K EPIC v2) for high-throughput profiling of the human DNA methylome.
Noguera-Castells A; García-Prieto CA; Álvarez-Errico D; Esteller M
Epigenetics; 2023 Dec; 18(1):2185742. PubMed ID: 36871255
[TBL] [Abstract] [Full Text] [Related]
14. A genetic disorder reveals a hematopoietic stem cell regulatory network co-opted in leukemia.
Voit RA; Tao L; Yu F; Cato LD; Cohen B; Fleming TJ; Antoszewski M; Liao X; Fiorini C; Nandakumar SK; Wahlster L; Teichert K; Regev A; Sankaran VG
Nat Immunol; 2023 Jan; 24(1):69-83. PubMed ID: 36522544
[TBL] [Abstract] [Full Text] [Related]
15. Isocitrate dehydrogenase 1 mutation drives leukemogenesis by PDGFRA activation due to insulator disruption in acute myeloid leukemia (AML).
Steinhäuser S; Silva P; Lenk L; Beder T; Hartmann A; Hänzelmann S; Fransecky L; Neumann M; Bastian L; Lipinski S; Richter K; Bultmann M; Hübner E; Xia S; Röllig C; Vogiatzi F; Schewe DM; Yumiceba V; Schultz K; Spielmann M; Baldus CD
Leukemia; 2023 Jan; 37(1):134-142. PubMed ID: 36411356
[TBL] [Abstract] [Full Text] [Related]
16. Subtype-specific 3D genome alteration in acute myeloid leukaemia.
Xu J; Song F; Lyu H; Kobayashi M; Zhang B; Zhao Z; Hou Y; Wang X; Luan Y; Jia B; Stasiak L; Wong JH; Wang Q; Jin Q; Jin Q; Fu Y; Yang H; Hardison RC; Dovat S; Platanias LC; Diao Y; Yang Y; Yamada T; Viny AD; Levine RL; Claxton D; Broach JR; Zheng H; Yue F
Nature; 2022 Nov; 611(7935):387-398. PubMed ID: 36289338
[TBL] [Abstract] [Full Text] [Related]
17. Population-based targeted RNA sequencing reveals novel disease-related gene fusions in pediatric and adult T-ALL.
Norvilas R; Batiuskaite R; Dirse V; Semaskeviciene R; Gineikiene E; Stoskus M; Vaitkeviciene G; Rascon J; Griskevicius L
Leuk Res; 2022 May; 116():106825. PubMed ID: 35339799
[TBL] [Abstract] [Full Text] [Related]
18. HOTTIP-dependent R-loop formation regulates ctcf boundary activity and TAD integrity in leukemia.
Luo H; Zhu G; Eshelman MA; Fung TK; Lai Q; Wang F; Zeisig BB; Lesperance J; Ma X; Chen S; Cesari N; Cogle C; Chen B; Xu B; Yang FC; So CWE; Qiu Y; Xu M; Huang S
Mol Cell; 2022 Feb; 82(4):833-851.e11. PubMed ID: 35180428
[TBL] [Abstract] [Full Text] [Related]
19. Tumour-derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8-mediated creatine import in NPM1-mutated acute myeloid leukaemia.
Peng M; Ren J; Jing Y; Jiang X; Xiao Q; Huang J; Tao Y; Lei L; Wang X; Yang Z; Yang Z; Zhan Q; Lin C; Jin G; Zhang X; Zhang L
J Extracell Vesicles; 2021 Nov; 10(13):e12168. PubMed ID: 34807526
[TBL] [Abstract] [Full Text] [Related]
20. Cancer drivers and clonal dynamics in acute lymphoblastic leukaemia subtypes.
Studd JB; Cornish AJ; Hoang PH; Law P; Kinnersley B; Houlston R
Blood Cancer J; 2021 Nov; 11(11):177. PubMed ID: 34753926
[TBL] [Abstract] [Full Text] [Related]
[Next]
